Search
for
Sort by
Research 61–90 of 1000+
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- An intergenerational androgenic mechanism of female intrasexual competition in the cooperatively breeding meerkat
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Rosmarinus officinalis L. (Rosemary) Extracts Containing Carnosic Acid and Carnosol are Potent Quorum Sensing Inhibitors of Staphylococcus aureus Virulence
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
- Androgen Receptor Ligands: Agonists and Antagonists
- Sodium Valproate Improves Skin Flap Survival via Gamma-Aminobutyric Acid and Histone Deacetylase Inhibitory System
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.
- Competitive balance of intrabulge BMP/Wnt signaling reveals a robust gene network ruling stem cell homeostasis and cyclic activation
- Deciphering principles of morphogenesis from temporal and spatial patterns on the integument
- Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Finasteride: the first 5 alpha-reductase inhibitor.
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Natural Melanogenesis Inhibitor, Antioxidant, and Collagen Biosynthesis Stimulator of Phytochemicals in Rice Bran and Husk Extracts from Purple Glutinous Rice (Oryza sativa L. cv. Pieisu 1 CMU) for Cosmetic Application
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors